Harvest Fund Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1
Closed 482
2026
Q1
$0 Hold
1
﹤0.01% 542
2025
Q4
$0 Hold
1
﹤0.01% 614
2025
Q3
$0 Sell
1
-481
-100% -$76.4K ﹤0.01% 645
2025
Q2
$73K Sell
482
-156
-24% -$20.8K ﹤0.01% 402
2025
Q1
$96K Buy
+638
New +$107K ﹤0.01% 441
2022
Q1
Sell
-504
Closed -$189K 748
2021
Q4
$189K Sell
504
-759
-60% -$295K 0.03% 253
2021
Q3
$520K Hold
1,263
0.12% 59
2021
Q2
$470K Buy
1,263
+298
+31% +$99.5K 0.05% 74
2021
Q1
$279K Hold
965
0.03% 107
2020
Q4
$241K Sell
965
-373
-28% -$88.8K 0.02% 129
2020
Q3
$314K Buy
1,338
+712
+114% +$148K 0.03% 112
2020
Q2
$109K Hold
626
0.01% 220
2020
Q1
$78K Buy
626
+549
+713% +$82.3K 0.01% 242
2019
Q4
$12K Hold
77
﹤0.01% 389
2019
Q3
$10K Sell
77
-582
-88% -$78K ﹤0.01% 368
2019
Q2
$94K Hold
659
0.01% 209
2019
Q1
$96K Hold
659
0.02% 198
2018
Q4
$75K Buy
+659
New +$82.5K 0.02% 221

Other funds holding CRL

Harvest Fund Management's CRL Position: Q2 2026 in Review

Harvest Fund Management sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1 share.

Harvest Fund Management first reported a position in CRL in Q4 2018 and held it in 18 quarters. The position peaked at $520K in Q3 2021. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Harvest Fund Management reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Harvest Fund Management sold 1 Charles River Laboratories share in Q2 2026.
  • Harvest Fund Management first reported a position in Charles River Laboratories in Q4 2018 and held it in 18 quarters.
  • Harvest Fund Management's Charles River Laboratories position peaked at $520K in Q3 2021.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.